Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
Amgen has set up this new centre in Hyderabad to further technologically develop its range of medicines. It is developing the ...
Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...
US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway ...
The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...
Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...
Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help ...
Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results